Evoke Pharma Inc

Nasdaq:EVOK

Pharmaceutical Preparations·SOLANA BEACH, CA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/14/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/13/25	→
10-Q	Q3 2024	9/30/24	11/7/24	→
10-Q	Q2 2024	6/30/24	8/13/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/13/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/13/25	Q2 FY2025	→
3/13/25	Q1 FY2025	→
11/7/24	Q4 FY2024	→
8/13/24	Q3 FY2024	→
↓

News (8-K)

61 shown

Filed	Type	Description
12/17/25	Delisting	Completion of Acquisition or Disposition of Assets	→
11/4/25	Exec Change	Entry into a Material Definitive Agreement	→
8/6/25	Other	Other Events	→
7/9/25	Other	Other Events	→
5/22/25	Vote	Submission of Matters to a Vote of Security Holders	→
2/24/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/17/25	S-8 POS	S-8 POS	→
12/17/25	S-8 POS	S-8 POS	→
12/17/25	S-8 POS	S-8 POS	→
12/17/25	S-8 POS	S-8 POS	→
12/17/25	S-8 POS	S-8 POS	→
4/10/25	ARS	ARS	→
↓

Filing History(665 filings)

TypeDateAccessionPeriodSize

15-12G

Dec 30, 2025

0001193125-25-33631515-12G

—

10.8 KB

Dec 19, 2025

0001104659-25-123156OWNERSHIP DOCUMENT

Dec 17, 2025

20.3 KB

SCHEDULE 13D/A

Dec 19, 2025

0001104659-25-123157

—

12.1 KB

EFFECT

Dec 18, 2025

9999999995-25-003825

—

1.7 KB

EFFECT

Dec 18, 2025

9999999995-25-003824

—

1.7 KB

EFFECT

Dec 18, 2025

9999999995-25-003821

—

1.7 KB

EFFECT

Dec 18, 2025

9999999995-25-003819

—

1.7 KB

EFFECT

Dec 18, 2025

9999999995-25-003818

—

1.7 KB

EFFECT

Dec 18, 2025

9999999995-25-003817

—

1.7 KB

S-8 POS

Dec 17, 2025

0001193125-25-322729S-8 POS

—

26.3 KB

S-8 POS

Dec 17, 2025

0001193125-25-322724S-8 POS

—

26.3 KB

S-8 POS

Dec 17, 2025

0001193125-25-322718S-8 POS

—

26.3 KB

S-8 POS

Dec 17, 2025

0001193125-25-322699S-8 POS

—

26.3 KB

S-8 POS

Dec 17, 2025

0001193125-25-322695S-8 POS

—

26.3 KB

POS AM

Dec 17, 2025

0001193125-25-322685POS AM

—

24.8 KB

POS AM

Dec 17, 2025

0001193125-25-322667POS AM

—

24.8 KB

POS AM

Dec 17, 2025

0001193125-25-322662POS AM

—

24.8 KB

POS AM

Dec 17, 2025

0001193125-25-322658POS AM

—

24.8 KB

POS AM

Dec 17, 2025

0001193125-25-322655POS AM

—

24.8 KB

Dec 17, 2025

0001193125-25-3226464

Dec 17, 2025

8.5 KB

Dec 17, 2025

0001193125-25-3226454

Dec 17, 2025

8.3 KB

POS AM

Dec 17, 2025

0001193125-25-322647POS AM

—

20.8 KB

Dec 17, 2025

0001193125-25-3226444

Dec 16, 2025

9.9 KB

Dec 17, 2025

0001193125-25-3226434

Dec 16, 2025

11.9 KB

Dec 17, 2025

0001193125-25-3226424

Dec 16, 2025

11.8 KB

25 filings shown

Filed	Form	Description
4/10/25	DEFA14A	DEFA14A	→
4/10/25	DEF 14A	DEF 14A	→
5/15/24	DEFA14A	DEFA14A	→
4/10/24	DEFA14A	DEFA14A	→
4/10/24	DEF 14A	DEF 14A	→
3/29/24	PRE 14A	PRE 14A	→
↓

Evoke Pharma Inc

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(665 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/19/25	4	OWNERSHIP DOCUMENT	→
12/17/25	4	4	→
12/17/25	4	4	→
12/17/25	4	4	→
12/17/25	4	4	→
12/17/25	4	4	→
↓

Filed	Form	Description
12/30/25	15-12G	15-12G	→
12/19/25	SCHEDULE 13D/A	SCHEDULE 13D/A	→
12/18/25	EFFECT	EFFECT	→
12/18/25	EFFECT	EFFECT	→
12/18/25	EFFECT	EFFECT	→
12/18/25	EFFECT	EFFECT	→
↓